Announcement on Adjusting the Purpose of Repurchased Shares and Cancellation

Securities Code: 002422 Securities Abbreviation: Kelun Pharmaceutical Announcement No.: 2026-027 Sichuan Kelun Pharmaceutical Co., Ltd. Announcement on Adjusting the Purpose of Repurchased Shares and Cancellation The Company and all members of its board of directors guarantee the content of the information disclosed is true, accurate, and complete, with no false records, misleading statements, or major omissions. Sichuan Kelun Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the twelfth meeting of the eighth board of directors on April 1, 2026, and reviewed and approved the "Proposal on Adjusting the Purpose of Repurchased Shares and Cancellation." The Company plans to adjust the purpose of the remaining 7,272,164 repurchased shares to "cancellation for capital reduction." Upon completion of this cancellation, the total share capital of the Company will change from 1,598,053,372 shares to 1,590,781,208 shares. This adjustment of the purpose of repurchased shares and cancellation is subject to the Company's shareholders' meeting for approval. The relevant situation is hereby announced as follows: I. Share Repurchase Plan and Implementation The Company's seventh board of directors, at its twelfth meeting held on Ap